Repros Theraup (NASDAQ:RPRX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

Recs

0
Player Avatar pchop123 (76.55) Submitted: 8/21/2012 9:20:02 AM : Underperform Start Price: $11.10 RPRX Score: -3.08

too high too fast even though it has potential to go somewhat higher

Featured Broker Partners


Advertisement